Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells

Acta Histochemica

Volumn 115, Issue 4, 2013, Pages 320-329

  Amsterdam, Abraham ^a   Raanan, Calanit ^a   Schreiber, Letizia ^b   Freyhan, Ora ^a   Fabrikant, Yakov ^c   Melzer, Ehud ^c   Givol, David ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Colon cancer; LGR5; Nanog; Pluripotent Stem cells

Indexed keywords

MEMBRANE RECEPTOR; PROTEIN LGR5; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CANCER STEM CELL; CELL LABELING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL NICHE;

CELL DIFFERENTIATION; COLON; COLONIC NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM GRADING; NEOPLASTIC STEM CELLS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84876301908     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2012.09.003     Document Type: Article

References (81)

1. Ambady S., Malcuit C., Kashpur O., Kole D., Holmes W.F., Hedblom E., et al. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. Int J Dev Biol 2010, 54:1743-1754.
2. Amsterdam A., Shezen E., Raanan C., Schreiber L., Prus D., Slilat Y., et al. Nuclear localization of phosphorylated ERK1 and ERK2 as markers for the progression of ovarian cancer. Int J Oncol 2011, 39:649-656.
3. Amsterdam A., Shezen E., Raanan C., Slilat Y., Ben-Arie A., Prus D., et al. Epiregulin as a marker for the initial steps of ovarian cancer development. Int J Oncol 2011, 39:1165-1172.
4. Amsterdam A., Shezen E., Raanan C., Schreiber L., Slilat Y., Fabrikant Y., et al. Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei of in aggregates at the perinuclear region of tumor cells. Int J Oncol 2012, 40:782-788.
5. Amsterdam A., Shezen E., Raanan C., Schreiber L., Slilat Y., Fabrikant Y., et al. Differential staining of γ synuclein in poorly differentiated compared to highly differentiated colon cancer cells. Oncol Rep 2012, 27:1451-1454.
6. Amsterdam A., Raanan C., Schreiber L., Freyhan O., Schechtman L., Givol D. Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship. Acta Histochem 2013, 115:330-338.
7. Baltus G.A., Kowalski M.P., Tutter A.V., Kadam S. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2. J Biol Chem 2009, 284:6998-7006.
8. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:217-229.
9. Barker N., van Es J.H., Jaks V., Kasper M., Snippert H., Toftgård R., et al. Very long-term self-renewal of small intestine, colon, and hair follicles from cycling Lgr5+ve stem cells. Cold Spring Harb Symp Quant Biol 2008, 73:351-356.
10. Boman B.M., Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008, 26:2828-2838.
11. Booth H.A., Holland P.W. Eleven daughters of NANOG. Genomics 2004, 84:229-238.
12. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
13. Chambers I., Tomlinson S.R. The transcriptional foundation of pluripotency. Development 2009, 136:2311-2322.
14. Chan K.K., Zhang J., Chia N.Y., Chan Y.S., Sim H.S., Tan K.S., et al. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells 2009, 27:2114-2125.
15. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008, 14:4085-4095.
16. Chiou S.H., Wang M.L., Chou Y.T., Chen C.J., Hong C.F., Hsieh W.J., et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 2010, 70:10433-10444.
17. Early D.S., Fontana L., Davidson N.O. Translation approaches to addressing complex genetic pathways in colorectal cancer. Transl Res 2008, 151:10-16.
18. Ezeh U.I., Turek P.J., Reijo R.A., Clark A.T. Human embryonic stem cell genes OCT4, NANOG STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005, 104:2255-2265.
19. Fairbanks D.J., Maughan P.J. Evolution of the NANOG pseudogene family in the human and chimpanzee genomes. BMC Evol Biol 2006, 6:12.
20. Fan X.S., Wu H.Y., Yu H.P., Zhou Q., Zhang Y.F., Huang Q. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Int J Colorectal Dis 2010, 25:583-590.
21. Gil Z., Cavel O., Kelly K., Brader P., Rein A., Gao S., et al. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst 2010, 102:107-118.
22. Han M.K., Song E.K., Guo Y., Ou X., Mantel C., Broxmeyer H.E. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008, 2:241-251.
23. Haramis A.P., Begthel H., van den Born M., van Es J., Jonkheer S., Offerhaus G.J., et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 2004, 303:1684-1686.
24. Hart A.H., Hartley L., Parker K., Ibrahim M., Looijenga L.H., Pauchnik M., et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005, 104:2092-2098.
25. Hattori N., Imao Y., Nishino K., Ohgane J., Yagi S., Tanaka S., et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 2007, 12:387-396.
26. He X.C., Zhang J., Tong W.G., Tawfik O., Ross J., Scoville D.H., et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 2004, 36:1117-1121.
27. Hsu S.Y., Liang S.G., Hsueh A.J. Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven transmembran region. Mol Endocrinol 1998, 12:1830-1845.
28. Huang Q., Zhang L.H. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Int J Surg Pathol 2007, 15:38-52.
29. Ishiguro T., Sato A., Ohata H., Sakai H., Nakagama H., Okamoto K. Differential expression of nanog1 and nanogp8 in colon cancer cells. Biochem Biophys Res Commun 2012, 418:199-204.
30. Jeter C.R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009, 27:993-1005.
31. Jeter C.R., Liu B., Liu X., Chen X., Liu C., Calhoun-Davis T., et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011, 30:3833-3845.
32. Karantzali E., Lekakis V., Ioannou M., Hadjimichael C., Papamatheakis J., Kretsovali A. Sall1 regulates embryonic stem cell differentiation in association with nanog. J Biol Chem 2011, 286:1037-1045.
33. Kashyap V., Rezende N.C., Scotland K.B., Shaffer S.M., Persson J.L., Gudas L.J., et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 2009, 18:1093-1108.
34. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998, 19:379-383.
35. Kuroda T., Tada M., Kubota H., Kimura H., Hatano S.Y., Suemori H., et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005, 25:2475-2485.
36. Leibig C., Gustavo A., Wilks J., Berger D., Albo D. Perineural invasion in cancer. Cancer 2009, 115:3379-3391.
37. Li H.C., Stoicov C., Rogers A.B., Houghton J. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006, 12:363-371.
38. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008, 10:731-739.
39. Lin T., Chao C., Saito S., Mazur S.J., Murphy M.E., Appella E., et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005, 7:165-171.
40. Liu C., Dong B., Lu A., Qu L., Xing X., Meng L., et al. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. BMC Cancer 2010, 10:359.
41. Liu N., Feng X., Fang Z., Ma F., Lu S., Lu M., et al. Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation. J Cell Biochem 2008, 104:2348-2362.
42. Lobo N.A., Shimono Y., Qian D. The biology of cancer promotes cell proliferation and tumor formation. Am J Pathol 2007, 173:835-843.
43. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006, 38:431-440.
44. Maitland N.J., Collins A.T. Prostate cancer stem cells: a new target for therapy. J Clin Oncol 2008, 26:2862-2870.
45. Mathieu J., Zhang Z., Zhou W., Wang A.J., Heddleston J.M., Pinna C.M., et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 2011, 71:4640-4652.
46. McClanahan T., Koseoglu S., Smith K., Grein J., Gustafson E., Black S., et al. Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther 2006, 5:419-426.
47. Meng H.M., Zheng P., Wang X.Y., Liu C., Sui H.M., Wu S.J., et al. Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol Ther 2010, 16:9.
48. Montgomery R.K., Breault D.T. Small intestinal stem cell markers. J Anat 2008, 213:52-58.
49. Morita H., Mazerbourg S., Bouley D.M., Luo C.W., Kawamura K., Kuwabara Y., et al. Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension. Mol Cell Biol 2004, 24:9736-9743.
50. Nicolis S.K. Cancer stem cells and " stemness" genes in neuro-oncology. Neurobiol Dis 2007, 25:217-229.
51. Nirasawa S., Kobayashi D., Tsuji N., Kuribayashi K., Watanabe N. Diagnostic relevance of overexpressed Nanog gene in early lung cancers. Oncol Rep 2009, 22:587-591.
52. Niwa H., Ogawa K., Shimosato D., Adachi K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009, 460:118-122.
53. Pan G., Thomson J.A. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007, 17:42-49.
54. Pan Y., Jiao J., Zhou C., Cheng Q., Hu Y., Chen H. Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade. Pathobiology 2010, 77:283-288.
55. Pierce G.B. Neoplastic stem cells. Adv Pathobiol 1977, 6:141-152.
56. Piestun D., Cochupurakkal B.S., Jacob-Hirsch J., Zeligson S., Domany E., Amariglio N., et al. Nanog transforms NIH3T3 and targets cell type restricted genes. Biochem Biophys Res Comm 2006, 343:279-285.
57. Po A., Ferretti E., Miele E., De Smaele E., Paganelli A., Canettieri G., et al. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J 2010, 29:2646-2658.
58. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-1909.
59. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005, 280:24731-24737.
60. Savarese F., Davila A., Nechanitzky R., De La Rosa-Velazquez I., Pereira C.F., Engelke R., et al. Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Devel 2009, 23:2625-2638.
61. + stem cell activity in mouse intestinal adenomas. Science 2012, 337(6095):730-735.
62. Silva J., Nichols J., Theunissen T.W., Guo G., van Oosten A.L., Barrandon O., et al. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
63. Suzuki A., Raya A., Kawakami Y., Morita M., Matsui T., Nakashima K., et al. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci USA 2006, 103:10294-10299.
64. Takao Y., Yokota T., Koide H. Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells. Biochem Biophys Res Commun 2007, 353:699-705.
65. Tanse K., Fukuma M., Yamada T., Mori T., Yoshikawa T., Watanabe W., et al. G-protein-coupled GPR49 is up-regulated in basal cell carcinoma and promoted cell proliferation and tumor formation. Am J Pathol 2008, 173:835-843.
66. Tay Y.M., Tam W.L., Ang Y.S., Gaughwin P.M., Yang H., Wang W., et al. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 2008, 26:17-29.
67. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
68. Torres J., Watt F.M. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3. Nat Cell Biol 2008, 10:194-201.
69. Vallier L., Mendjan S., Brown S., Chang Z., Teo A., Smithers L.E., et al. Activin/nodal signalling maintains pluripotency by controlling Nanog expression. Development 2009, 136:1339-1349.
70. Van Es J.H., van Gijn M.E., Riccio O., van den Born M., Vooijs M., Begthel H., et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963.
71. Van der Flier L.G., Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2008, 71:241-260.
72. Villasante A., Piazzolla D., Li H., Gomez-Lopez G., Djabali M., Serrano M. Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. Cell Cycle 2011, 10:1488-1498.
73. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
74. Wen J., Park J.Y., Park K.H., Chung H.W., Bang S., Park S.W., et al. Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas 2010, 39:622-626.
75. Wu Q., Chen X., Zhang J., Loh Y.H., Low T.Y., Zhang W., et al. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem 2006, 281:24090-24094.
76. Xu R.H., Sampsell-Barron T.L., Gu F., Root S., Peck R.M., Pan G., et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008, 3:196-206.
77. Yamamoto Y., Sakamoto M., Fujii G., Tsuiji H., Kenetaka K., Asaka M., et al. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations. Hepatology 2003, 37:528-533.
78. Ye F., Zhou C., Cheng Q., Shen J., Chen H Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 2008, 8:108.
79. Zhang J., Wang X., Li M., Han J., Chen B., Wang B., et al. NANOGP8 is a retrogene expressed in cancers. FEBS J 2006, 273:1723-1730.
80. Zhang P., Andrianakos R., Yang Y., Liu C., Lu W. Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J Biol Chem 2010, 285:9180-9189.
81. Zbinden M., Duquet A., Lorente-Trigos A., Ngwabyt S.N., Borges I., Ruiz A. I Altaba NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 2010, 29:2659-2674.